Clinical Trials Directory

Trials / Completed

CompletedNCT05300542

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

Efficacy Study of a Novel Cosmetic Product to Reduce an UVB Induced Erythema

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Amazentis SA · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to determine the erythema-reducing efficacy of a test product in two concentrations on a light sunburn induced by a sun simulator compared to an untreated control and a placebo product.

Conditions

Interventions

TypeNameDescription
OTHERTopical Placebo CreamApplication of test products before and after irradiation
OTHERTopical Cream with 0.5% ActiveApplication of test products before and after irradiation
OTHERTopical Cream with 1% ActiveApplication of test products before and after irradiation

Timeline

Start date
2022-03-17
Primary completion
2022-03-31
Completion
2022-04-13
First posted
2022-03-29
Last updated
2023-04-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05300542. Inclusion in this directory is not an endorsement.

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema (NCT05300542) · Clinical Trials Directory